nodes	percent_of_prediction	percent_of_DWPC	metapath
Hydroxyurea—Chronic myeloid leukaemia—Thalidomide—leprosy	0.17	0.17	CcSEcCtD
Hydroxyurea—Anaemia megaloblastic—Thalidomide—leprosy	0.0679	0.0679	CcSEcCtD
Hydroxyurea—Leukaemia—Thalidomide—leprosy	0.0594	0.0594	CcSEcCtD
Hydroxyurea—Skin necrosis—Thalidomide—leprosy	0.0458	0.0458	CcSEcCtD
Hydroxyurea—Skin exfoliation—Dapsone—leprosy	0.0298	0.0298	CcSEcCtD
Hydroxyurea—Platelet count decreased—Thalidomide—leprosy	0.0269	0.0269	CcSEcCtD
Hydroxyurea—Febrile neutropenia—Thalidomide—leprosy	0.0266	0.0266	CcSEcCtD
Hydroxyurea—Hypomagnesaemia—Thalidomide—leprosy	0.0252	0.0252	CcSEcCtD
Hydroxyurea—Skin ulcer—Thalidomide—leprosy	0.0206	0.0206	CcSEcCtD
Hydroxyurea—Pancreatitis—Dapsone—leprosy	0.0192	0.0192	CcSEcCtD
Hydroxyurea—Amenorrhoea—Thalidomide—leprosy	0.0182	0.0182	CcSEcCtD
Hydroxyurea—Hyperuricaemia—Thalidomide—leprosy	0.0172	0.0172	CcSEcCtD
Hydroxyurea—Neuropathy peripheral—Dapsone—leprosy	0.0171	0.0171	CcSEcCtD
Hydroxyurea—Creatinine increased—Thalidomide—leprosy	0.0168	0.0168	CcSEcCtD
Hydroxyurea—Blood uric acid increased—Thalidomide—leprosy	0.0163	0.0163	CcSEcCtD
Hydroxyurea—Skin exfoliation—Thalidomide—leprosy	0.0153	0.0153	CcSEcCtD
Hydroxyurea—Blood urea increased—Thalidomide—leprosy	0.0151	0.0151	CcSEcCtD
Hydroxyurea—Rash maculo-papular—Thalidomide—leprosy	0.0145	0.0145	CcSEcCtD
Hydroxyurea—Pulmonary oedema—Thalidomide—leprosy	0.0142	0.0142	CcSEcCtD
Hydroxyurea—Erythema—Dapsone—leprosy	0.0137	0.0137	CcSEcCtD
Hydroxyurea—Renal failure acute—Thalidomide—leprosy	0.0126	0.0126	CcSEcCtD
Hydroxyurea—Dermatitis bullous—Thalidomide—leprosy	0.0122	0.0122	CcSEcCtD
Hydroxyurea—Face oedema—Thalidomide—leprosy	0.0112	0.0112	CcSEcCtD
Hydroxyurea—Blood creatinine increased—Thalidomide—leprosy	0.0109	0.0109	CcSEcCtD
Hydroxyurea—Breast disorder—Thalidomide—leprosy	0.0105	0.0105	CcSEcCtD
Hydroxyurea—Pancreatitis—Thalidomide—leprosy	0.00984	0.00984	CcSEcCtD
Hydroxyurea—Pancytopenia—Thalidomide—leprosy	0.00953	0.00953	CcSEcCtD
Hydroxyurea—Neutropenia—Thalidomide—leprosy	0.00939	0.00939	CcSEcCtD
Hydroxyurea—Weight increased—Thalidomide—leprosy	0.00914	0.00914	CcSEcCtD
Hydroxyurea—Drowsiness—Thalidomide—leprosy	0.00895	0.00895	CcSEcCtD
Hydroxyurea—Infestation NOS—Thalidomide—leprosy	0.00895	0.00895	CcSEcCtD
Hydroxyurea—Infestation—Thalidomide—leprosy	0.00895	0.00895	CcSEcCtD
Hydroxyurea—Body temperature increased—Dapsone—leprosy	0.00881	0.00881	CcSEcCtD
Hydroxyurea—Neuropathy peripheral—Thalidomide—leprosy	0.00877	0.00877	CcSEcCtD
Hydroxyurea—Stomatitis—Thalidomide—leprosy	0.00872	0.00872	CcSEcCtD
Hydroxyurea—Angiopathy—Thalidomide—leprosy	0.00729	0.00729	CcSEcCtD
Hydroxyurea—Chills—Thalidomide—leprosy	0.00721	0.00721	CcSEcCtD
Hydroxyurea—Alopecia—Thalidomide—leprosy	0.0071	0.0071	CcSEcCtD
Hydroxyurea—Vomiting—Dapsone—leprosy	0.00709	0.00709	CcSEcCtD
Hydroxyurea—Headache—Dapsone—leprosy	0.00699	0.00699	CcSEcCtD
Hydroxyurea—Nausea—Dapsone—leprosy	0.00662	0.00662	CcSEcCtD
Hydroxyurea—Ill-defined disorder—Thalidomide—leprosy	0.00649	0.00649	CcSEcCtD
Hydroxyurea—Anaemia—Thalidomide—leprosy	0.00646	0.00646	CcSEcCtD
Hydroxyurea—Malaise—Thalidomide—leprosy	0.00631	0.00631	CcSEcCtD
Hydroxyurea—Leukopenia—Thalidomide—leprosy	0.00626	0.00626	CcSEcCtD
Hydroxyurea—Convulsion—Thalidomide—leprosy	0.00606	0.00606	CcSEcCtD
Hydroxyurea—Unspecified disorder of skin and subcutaneous tissue—Thalidomide—leprosy	0.00591	0.00591	CcSEcCtD
Hydroxyurea—Discomfort—Thalidomide—leprosy	0.00588	0.00588	CcSEcCtD
Hydroxyurea—Oedema—Thalidomide—leprosy	0.00571	0.00571	CcSEcCtD
Hydroxyurea—Infection—Thalidomide—leprosy	0.00567	0.00567	CcSEcCtD
Hydroxyurea—Nervous system disorder—Thalidomide—leprosy	0.0056	0.0056	CcSEcCtD
Hydroxyurea—Thrombocytopenia—Thalidomide—leprosy	0.00559	0.00559	CcSEcCtD
Hydroxyurea—Skin disorder—Thalidomide—leprosy	0.00554	0.00554	CcSEcCtD
Hydroxyurea—Anorexia—Thalidomide—leprosy	0.00544	0.00544	CcSEcCtD
Hydroxyurea—Dyspnoea—Thalidomide—leprosy	0.00509	0.00509	CcSEcCtD
Hydroxyurea—Somnolence—Thalidomide—leprosy	0.00507	0.00507	CcSEcCtD
Hydroxyurea—Dyspepsia—Thalidomide—leprosy	0.00502	0.00502	CcSEcCtD
Hydroxyurea—Decreased appetite—Thalidomide—leprosy	0.00496	0.00496	CcSEcCtD
Hydroxyurea—Gastrointestinal disorder—Thalidomide—leprosy	0.00493	0.00493	CcSEcCtD
Hydroxyurea—Fatigue—Thalidomide—leprosy	0.00492	0.00492	CcSEcCtD
Hydroxyurea—Constipation—Thalidomide—leprosy	0.00488	0.00488	CcSEcCtD
Hydroxyurea—Pain—Thalidomide—leprosy	0.00488	0.00488	CcSEcCtD
Hydroxyurea—Feeling abnormal—Thalidomide—leprosy	0.0047	0.0047	CcSEcCtD
Hydroxyurea—Body temperature increased—Thalidomide—leprosy	0.00451	0.00451	CcSEcCtD
Hydroxyurea—Hypersensitivity—Thalidomide—leprosy	0.00421	0.00421	CcSEcCtD
Hydroxyurea—Asthenia—Thalidomide—leprosy	0.0041	0.0041	CcSEcCtD
Hydroxyurea—Diarrhoea—Thalidomide—leprosy	0.00391	0.00391	CcSEcCtD
Hydroxyurea—Dizziness—Thalidomide—leprosy	0.00377	0.00377	CcSEcCtD
Hydroxyurea—Vomiting—Thalidomide—leprosy	0.00363	0.00363	CcSEcCtD
Hydroxyurea—Rash—Thalidomide—leprosy	0.0036	0.0036	CcSEcCtD
Hydroxyurea—Dermatitis—Thalidomide—leprosy	0.0036	0.0036	CcSEcCtD
Hydroxyurea—Headache—Thalidomide—leprosy	0.00358	0.00358	CcSEcCtD
Hydroxyurea—Nausea—Thalidomide—leprosy	0.00339	0.00339	CcSEcCtD
